Commercialization News

If you’re looking to stay up to date with the latest commercialization news out of the Office of Research and Technology Management at Case Western Reserve University, you’ve come to the right place. Explore some of our latest headlines relating to inventions, startups and more from researchers at CWRU.


2025

Trailhead Biosystems Secures $20 Million to Drive Innovation and Accelerate Growth
Trailhead Biosystems | May 6, 2025

Tevard to Present Data Demonstrating tRNA-based Therapy Rescued Full-Length Dystrophin and Motor Function in Duchenne Muscular Dystrophy Model
BioSpace | April 29, 2025

Umut Gurkan recognized with 2025 Distinguished Investigator Award for Translation from Proof of Concept to Widespread Clinical Practice
The Daily | April 25, 2025

The rise of robotics: CWRU projects helping shape our future=
The Daily | April 11, 2025

Y-12 to utilize extended reality platform used to train healthcare workers, dancers
WATE | April 10, 2025

Biohm Technologies secures $4.52M funding to drive next phase of growth
NutraIngredients USA | April 7, 2025

Will tRNA therapy be the next big thing in genetic disease treatment?
Labiotech | April 7, 2025

Innovative “crab robot” startup is borne out of a budding CWRU program
Crain’s Cleveland Business | April 3, 2025

Verizon Business announces Partner Recognition Program winners at 2025 Channel Partners Conference & Expo
Global NewsWire | March 24, 2025

Luminary Therapeutics to Develop Allogenic CAR T Therapy for Targeting Solid Tumors
PR Newswire | March 11, 2025

Trailhead Biosystems® Develops iPSC-Derived Vascular Leptomeningeal Cells
Trailhead Biosystems | March 5, 2025

Symphony Robotics Licenses New Robotics Technology to Fight Brain Tumors
BusinessWire | Feb. 11, 2025

NervGen Completes Dosing of First Subject in Subacute Cohort of its Phase 1b/2a Clinical Trial of NVG-291 in Spinal Cord Injury
NervGen | Feb. 6, 2025

Neuros Medical and Veterans Healthcare Supply Solutions Partner to Provide Revolutionary Treatment for Chronic Post-Amputation Pain to Veteran and Active-Duty Military Amputees at VA Healthcare and Military Treatment Facilities
PR Newswire | Feb. 5, 2025

Biotech firm CollaMedix charts big growth in new Cleveland facility
Crain’s Cleveland Business | Jan. 17, 2025

Electronics Scrap Recycling Advancement Prize
Energy.gov | Jan. 8, 2025

 

2024

University Hospitals Haslam Sports Innovation Center Makes First Investments in Sports Medicine Innovation
University Hospitals | Dec. 17, 2024

Digital Storage And Memory Projections For 2025, Part 2
Forbes | Dec. 11, 2024

Two New Solutions from Hemex Health Empower More Clinicians and Health Workers to Test for Iron Deficiency Anaemia and Sickle Cell Disease
Global NewsWire | Nov. 14, 2024

ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics
PR Newswire | Oct. 29, 2024

Seasoned startups: MAGNET Mspire pitch competition puts mature companies in spotlight
FreshWater | Oct. 24, 2024

Biohm and ADM partner on microbiome formulation for women
NutraIngredients USA | Oct. 16, 2024

Twelve-Month Results from Landmark QUEST Study Published in Neuromodulation
PR Newswire | Sept. 26, 2024

NIH Awards Kevin Kilgore, PhD, $2.2 Million in Grants
MetroHealth | Sept. 9, 2024

Neuros Medical Receives FDA Approval for the Altius® Direct Electrical Nerve Stimulation System
PR Newswire | Aug. 28, 2024

Robotic street painter takes over Downtown Cleveland, saving the city manpower and cash
News 5 Cleveland | Aug. 22, 2024

Phase 1 BAFF CAR T Clinical Trial for Patients with Relapsed and Refractory Multiple Myeloma Underway at UH Seidman Cancer Center
University Hospitals | Aug. 9, 2024

Chemical engineer Rohan Akolkar earns top honors from ECS
The Daily | July 12, 2024

NervGen Pharma to Advance NVG-300 into Preclinical Proof-of-Concept Stage
NervGen | June 25, 2024

Mission Possible: Case Western, Cleveland company research creating artificial blood
DefiniGEN | June 3, 2024

Beachwood’s strategic focus on local business growth attracts innovation to Commerce Park
Crain’s Cleveland Business | March 18, 2024

BIOHM Health Inc. Partners with Virginia Tech to Accelerate Bacterial and Fungal Microbiome-Based Product Development and Commercialization through A.I.
PR Newswire | March 7, 2024

Meet Electra, the robot that may one day paint your roads
Crain’s Cleveland Business | Feb. 20, 2024

Company co-founded by Case Western Reserve University researcher named finalist in South by Southwest pitch competition
The Daily | Feb. 19, 2024

AlensiaXR Series A Funding Round to Evolve Anatomical Instruction Using Holograms
BusinessWire | Feb. 1, 2024

CES 2024: Most-ever inventors from Case Western Reserve to showcase their innovations at Las Vegas exhibition for 11th straight year
The Daily | Jan. 5, 2024


2023

Any Target, Every Time - How molecular “matchmaking” could pave the way for drug development to target the 85% of molecules considered undruggable.
Amgen.com | Nov. 28, 2023

Revolutionizing road safety: RoadPrintz puts groundbreaking robotic pavement-marking system to use across Cleveland
The Daily | Nov. 15, 2023

Lucid Diagnostics Announces PREVENT and PREVENT-FF Registries of EsoGuard® Esophageal Precancer Detection
Luciddx.com | Oct. 31, 2023

NervGen Pharma Receives Fast Track Designation for NVG-291 for the Treatment of Individuals with Spinal Cord Injury
Nervgen.com | Oct. 23, 2023

NervGen Pharma Announces First Subject Dosed in Landmark Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury
Nervgen.com | Sept. 25, 2023

When a Network Matters! Functional iPSC-derived Endothelial Cells Finally Arrive
Bioinformant | Sept. 18, 2023

‘Great news for patients:’ Breathing device from UH, CWRU to help more paralyzed patients
Cleveland.com | July 25, 2023

Two NE Ohio startups land Ohio Third Frontier grants
Crain's Cleveland Business | July 11, 2023

Lucid Diagnostics and Collaborators Present New EsoGuard® and EsoCheck® Data at Digestive Disease Week® (DDW) 2023 Conference
PAVmed | May 11, 2023

Biomarkers and Balloons Help in the Fight Against Esophageal Cancer
AUTM | April 21, 2023

Lucid Diagnostics Reports Publication of Future Effective Foundational Local Coverage Determination by Medicare Administrative Contractor Noridian Healthcare Solutions
PAVmed | April 18, 2023

NervGen Pharma Presenting Phase 1b/2a Study Design at American Spinal Injury Association 50th Annual Scientific Meeting
NervGen | April 13, 2023

Oberlin-based Synapse Biomedical receives FDA approval for breathing device used by Christopher Reeve
Cleveland.com | April 5, 2023

NervGen Pharma Reports 2022 Year End Results and Provides Operational Update Including Plans to Initiate Phase 1b/2a Clinical Trial of Proprietary NVG-291 in Q3 2023
NervGen | March 30, 2023

Biohm partners with Life Extension to design targeted microbiome supplements
NutraIngredients USA | March 16, 2023

CWRU creates company to market its HoloAnatomy software that teaches cadaver-free anatomy
Cleveland.com | March 15, 2023

Case Western Reserve University completes exclusive license agreement with Atlanta-based RORA Biologics Inc. for cancer and HIV therapy technologies
The Daily | March 8, 2023

BIOHM Probiotic Products Gain Investment from Valley Growth Ventures
The Business Journal Daily | March 8, 2023

Case Western Reserve University completes exclusive license agreement with Atlanta-based RORA Biologics Inc. for cancer and HIV therapy technologies
The Daily | Feb. 23, 2023

CWRU reaches international licensing deal with Atlanta company
Crain's Cleveland Business | Feb. 23, 2023

Lucid Diagnostics Holds First #CheckYourFoodTube Precancer Testing Event
PAVmed | Feb. 15, 2023

National Academy of Inventors names eight Case Western Reserve University researchers to 2023 class of senior members
The Daily | Feb. 14, 2023

NervGen Pharma Announces Completion of Dosing of All Subjects in Phase 1 Clinical Trial of Proprietary Drug Candidate NVG-291
NervGen | Feb. 14, 2023

Bringing ideas to market: CWRU researchers turn discoveries into inventions
The Daily | Feb. 13, 2023

St. Joseph students studying anatomy in virtual reality
Fox 8 WJW | Feb. 7, 2023

This Week In XR: $18 Million For Gemba VR Training, Dreamscape Learn Spins Off With $20 Million
Forbes | Jan. 27, 2023

$578 million for Greater Cleveland’s startups: These 23 companies raised the most cash in 2022
The Plain Dealer | Jan. 26, 2023

New company from Case Western Reserve University helps medical students learn anatomy through holographic imagery
Ideastream Public Media | Jan. 26, 2023

Making blood in the lab: Facing donor shortages and storage limitations, researchers are developing synthetic red blood cells, platelets, and plasma and combining them into artificial blood.
Drug Discovery and Development | Jan. 18, 2023

Case Western Reserve University launches Ilumis: Startup to accelerate and scale adoption of pioneering HoloAnatomy software to transform the way students learn human anatomy
The Daily | Jan. 17, 2023


2022

Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry
Lucid Diagnostics | Dec. 8, 2022

Researchers Markowitz, Tyler elected fellows for 2022 class of National Academy of Inventors
The Daily | Dec. 8, 2022

Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research
Lucid Diagnostics | Dec. 1, 2022

Exclusive license agreement with Case Western Reserve University for Core-NK platform
Chimeric Therapeutics | Nov. 21, 2022

Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research
PAVmed | Dec. 1, 2022

Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry
PAVmed | Dec. 8, 2022

Researchers Markowitz, Tyler elected fellows for 2022 class of National Academy of Inventors
The Daily | Dec. 8, 2022

Case Western Reserve University receives $1M state grant for technology start-up fund
The Daily | Nov. 21, 2022

Third Frontier Provides Funds to Accelerate Innovation
Ohio Department of Development | Oct. 18, 2022

NervGen Pharma Receives FDA Authorization to Expand Enrollment of Males and Premenopausal Females in Phase 1 Clinical Trial of NervGen's NVG-291
NervGen | Oct. 25, 2022

A ‘game changer’ for people with sickle cell disease: Case Western Reserve University researcher, company, collaborating to develop blood test measuring the effects, potency of new gene therapies for sickle cell disease
The Daily | Sept. 14, 2022

Top faculty to be honored during CWRU’s inaugural Innovation Week
The Daily | Sept. 8, 2022

An inventive spirit, an impressive ranking
The Daily | Sept. 8, 2022

A ‘game changer’ for people with sickle cell disease
The Daily | Sept. 9, 2022

Folio Photonics Announces Breakthrough Multi-Layer Optical Disc Storage Technology to Enable Industry-Disruptive Cost, Cybersecurity and Sustainability Benefits
Folio Photonics | Aug. 30, 2022

Lucid Diagnostics Launches Stage II Lucid Test Center Expansion in California, Texas, Florida, and Ohio
PAVmed | Aug. 11, 2022

NervGen Pharma Reports Second Quarter 2022 Results and Provides Corporate Update
NervGen | Aug. 10, 2022

Newly Published American Gastroenterological Association Clinical Practice Update Supports Esophageal Precancer Screening Using Lucid Diagnostics’ EsoGuard® and EsoCheck® Technologies
Lucid Diagnostics | Aug. 4, 2022

NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Repair From a Stroke 7 Days After Onset in Landmark Preclinical Study by University of Cincinnati and Case Western Reserve University
BusinessWire | Aug. 3, 2022

NervGen Presenting Study Design for Upcoming Phase 1b/2a in Alzheimer's Disease at the 2022 Alzheimer's Association International Conference
NervGen | Aug. 2, 2022

Lucid Diagnostics’ Laboratory Executes Four New Participating Provider Agreements
PAVmed | Aug. 2, 2022

NervGen Pharma Closes US$15MM Private Placement and Appoints Dr. Adam Rogers to Board of Directors
NervGen | July 14, 2022

RAD adds brain tumor technology to portfolio
Radiopharm Theranostics | June 9, 2022

Case Western Reserve University signs license agreement to bring artificial intelligence breakthroughs closer to cancer patient care
The Daily | May 25, 2022

Mosaic ImmunoEngineering Announces Completion of Exclusive Technology License Agreement with Case Western Reserve University
AccessWire | May 12, 2022

Lucid Diagnostics’ Laboratory Executes Participating Provider Agreement with MediNcrease Health Plans
PAVmed | May 9, 2022

Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination
PAVmed | April 4, 2022

NervGen Presenting Interim Phase 1 Clinical Trial Data for NVG-291 at the 2022 American Academy of Neurology Annual Meeting
NervGen | March 31, 2022

PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study
PAVmed | March 24, 2022

PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
PAVmed | March 23, 2022

NervGen Pharma Receives Approval from Safety Review Committee to Proceed to Second Cohort in Multiple Ascending Dose Portion of Phase 1 Clinical Trial of NVG-291
NervGen | March 15, 2022

PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing Growth
PAVmed | March 3, 2022

Three Case Western Reserve University faculty elected as 2022 Senior Members of National Academy of Inventors
The Daily | Feb. 11, 2022

Case Western Reserve University grants exclusive license to Ionis Pharmaceuticals to advance antisense therapy for Pelizaeus-Merzbacher disease
The Daily | Jan. 27, 2022

Road-painting robot created in Northeast Ohio could save lives
News 5 Cleveland | Jan. 21, 2022

Case Western Reserve University partners with Produce Perks Midwest, expanding nutrition-incentive technology at farmers’ markets
The Daily | Jan. 20, 2022

CWRU On Track
Crain's Cleveland Business | Jan. 20, 2022

CWRU inks licensing deal to commercialize an imaging agent to aid in brain tumor surgery
Crain's Cleveland Business | Jan. 19, 2021

Cleveland-based RoadPrintz Inc. receives $1M from National Science Foundation to advance mobile robotic pavement-marking system
The Daily | Jan. 5, 2022